RELEASE
A phase I/II dose-escalation multi center study to evaluate the safety of infusion of NatuRal KillEr celLs or MEmory T cells as Adoptive therapy in coronaviruS pnEumonia and/or lymphopenia
A phase I/II dose-escalation multi center study to evaluate the safety of infusion of NatuRal KillEr celLs or MEmory T cells as Adoptive therapy in coronaviruS pnEumonia and/or lymphopenia
Log in or sign up for Devpost to join the conversation.